No Danger Here

One of the main worries that bioethicists and others have about personal genetic testing is how people react to receiving such information, particularly how they handle learning about incidental findings. But, this question of "how much information is too much information?" is actually the "wrong question," writes Virginia Hughes at Slate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.